Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.3210
-0.0050 (-1.53%)
At close: Aug 21, 2026
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €6.11 million as of August 21, 2026. Its market cap has decreased by -12.62% in one year.
Market Cap
6.11M
Enterprise Value
10.38M
Revenue
1.81M
Ranking
n/a
PE Ratio
1.07
Stock Price
€0.32
ChartMarket Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has increased from 5.82M to 6.11M, an increase of 4.95%. That is a compound annual growth rate of 1.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 6.11M | -18.14% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 24.67M |
| Advicenne | 24.44M |
| genOway Société anonyme | 22.59M |
| Aelis Farma | 14.66M |
| Aton | 12.42M |
| Biophytis | 11.54M |
| NFL Biosciences | 11.00M |
| Poxel | 10.54M |